Literature DB >> 28045647

Nucleic acid components and their analogs: Design and synthesis of novel cytosine thioglycoside analogs.

Galal H Elgemeie1, Ali M Salah1, Nermeen S Abbas1,2, Hoda A Hussein3, Reham A Mohamed3.   

Abstract

The synthesis of a new category of novel cytosine 4-thioglycoside analogs has been first accomplished. The main step of this strategy is the synthesis of sodium pyrimidine-4-thiolate through the condensation of 2-cyano-N-arylacetamides with sodium cyanocarbonimidodithioate, followed by coupling with α-bromo-sugars to afford the corresponding cytosine 4-thioglycoside analogs. The free thioglycosides were also prepared. Subsequent studies on the application of this strategy for the preparation of other potent pyrimidine thioglycosides are reported.

Entities:  

Keywords:  2-cyano-N-arylacetamides; Pyrimidine thioglycosides; antimetabolites; sodium cyanocarbonimidodithioate

Mesh:

Substances:

Year:  2017        PMID: 28045647     DOI: 10.1080/15257770.2016.1231318

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  3 in total

1.  Synthesis, characterization, and antimicrobial evaluation of novel 5-benzoyl-N-substituted amino- and 5-benzoyl-N-sulfonylamino-4-alkylsulfanyl-2-pyridones.

Authors:  Galal Elgemeie; Farag Altalbawy; Mohammed Alfaidi; Rania Azab; Atef Hassan
Journal:  Drug Des Devel Ther       Date:  2017-11-28       Impact factor: 4.162

2.  Novel purine thioglycoside analogs: synthesis, nanoformulation and biological evaluation in in vitro human liver and breast cancer models.

Authors:  Mamdouh A Abu-Zaied; Samah A Loutfy; Ashraf E Hassan; Galal H Elgemeie
Journal:  Drug Des Devel Ther       Date:  2019-07-26       Impact factor: 4.319

3.  Crystal structure of racemic 2-[(β-arabino-pyran-osyl)-sulfanyl]-4,6-diphenylpyridine-3-carbo-nitrile.

Authors:  Sherif F Hammad; Doaa M Masoud; Galal H Elgemeie; Peter G Jones
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.